Get all your news in one place.
100's of premium titles.
One app.
Start reading
Louder
Louder
Entertainment
Paul Brannigan

Ginger Wildheart diagnosed with "rare but aggressive" type of cancer, Mantle Cell Lymphoma

Ginger Wildheart studio portrait.

Ginger Wildheart has been diagnosed with cancer.

The news was shared with fans in a statement posted on the band's social media accounts today, March 16. It reads:

"During The Wildhearts’ incredible More Satanic Rites UK tour in December 2025, frontman and founding member Ginger Wildheart was experiencing severe pains that some nights forced him to take some short breaks from stage. Determined not to upset the band’s loyal fans – new and old – Ginger took painkillers to ensure the rock’n’roll was delivered, without missing a riff.

“Away from the tour Ginger has sought medical tests and investigations to establish the cause of the ongoing issue. The results have been confirmed and we are saddened to report that Ginger has been diagnosed with Mantle Cell Lymphoma (MCL) – a rare but aggressive strain of cancer.”

The statement goes on to insist that the 61-year-old South Shields musician is "fine fettle", is currently writing new material for the follow up to last year's Satanic Rites of the Wildhearts album and future solo projects, and will be honouring all gig commitments currently in place for the band.

"While we process this news and await further medical advice, Ginger wants everyone to know that strength and positivity will prevail and the show will go on," the statement adds. "Make sure you come and see The Wildhearts – sounding bigger and more refreshingly amazing than ever – at a venue near you soon."


Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.